Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 24 May 2024 – 20 Aug 2026, limited by Groww Nifty Non-Cyclical Consumer Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww Nifty Non-Cyclical Consumer Index Fund | Nifty 500 |
|---|---|---|
| 24 May 2024 | ₹100.00 | ₹100.00 |
| 31 Jul 2024 | ₹111.35 | ₹109.53 |
| 07 Oct 2024 | ₹116.18 | ₹107.90 |
| 15 Dec 2024 | ₹110.88 | ₹108.73 |
| 21 Feb 2025 | ₹98.95 | ₹96.31 |
| 30 Apr 2025 | ₹106.63 | ₹102.54 |
| 07 Jul 2025 | ₹109.69 | ₹109.62 |
| 13 Sep 2025 | ₹112.14 | ₹107.94 |
| 20 Nov 2025 | ₹111.29 | ₹111.60 |
| 28 Jan 2026 | ₹100.87 | ₹107.44 |
| 06 Apr 2026 | ₹93.51 | ₹98.65 |
| 13 Jun 2026 | ₹98.16 | ₹105.19 |
| 20 Aug 2026 | ₹104.45 | ₹109.45 |
| Metric | Groww · Regular · IDCW NAV ₹10.44 Very High risk ★☆☆☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| -7.90% | +4.72% | |
| — | +7.52% | |
| — | +8.28% | |
| — | +9.00% | |
| +1.97% | +7.27% | |
| -1.48% | — | |
| — | +7.88% | |
| — | +10.94% | |
| — | +9.63% | |
| Risk | ||
| 14.36% | 13.54% | |
| -1.00 | 0.11 | |
| -1.41 | 0.15 | |
| -27.36% | -15.67% | |
| Nifty 500 | — | |
| — | -0.05% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 99.5% | |
| 1.09% | 0.88% | |
| ₹41.12Cr | ₹181.49Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹100 | — | |
| 24% | 38% | |
| Nikhil Satam | — | |
| 24 May 2024 | — | |
| 30 | — | |
| 66.4% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.